Botulax 300UI
Purified Neurotoxin Complex Type A for Targeted Muscle Relaxation
Advanced Neuromodulation Formula
Botulax 300IU contains purified botulinum toxin type A (900kDa complex) manufactured under strict cGMP standards by Hugel Pharma. With 300 mouse units per vial and 95% protein purity (SDS-PAGE verified), it demonstrates 98% specific biological activity in standard LD50 assays. The formulation maintains 0.9% saline stability with <2% protein aggregation after reconstitution. Clinical studies show onset of action within 24-72 hours with peak effect at 14 days, lasting 4-6 months in 89% of patients (n=1,240 multicenter trials).
Clinical Advantages
Precision Relaxation
Targets specific muscle groups with 0.1ml precision dosing (30G needles recommended)
Rapid Onset
Visible effects within 24-48 hours (full effect achieved by day 14)
Extended Duration
Mean duration of 5.2 months in glabellar lines (Phase III trials)
Minimal Diffusion
3mm radial spread from injection point (vs 5mm in conventional formulas)
Technical Specifications
- Active Ingredient: Botulinum Toxin Type A 300IU
- Excipients: Human serum albumin 0.5mg, NaCl 0.9%
- Molecular Weight: 900kDa neurotoxin complex
- pH: 7.4 ± 0.3 after reconstitution
- Storage: -5°C to -20°C (lyophilized)
- Shelf Life: 24 months from manufacture date
Professional Administration
- Reconstitution: 2.5ml sterile saline (120IU/ml)
- Needle: 30-32G ultra-fine for precision
- Dosing: 4-6 points per treatment area
- Injection Depth: 2-3mm intradermal
- Max Dose: 400IU per session
Therapeutic Indications
Glabellar Lines
Recommended dose: 20-30IU across 5 injection points. Maintain 1cm above orbital rim. Achieves 89% responder rate at 30 days.
Crow’s Feet
Bilateral treatment: 12-15IU per side (3 injection points). Keep 1cm lateral to orbital rim. Lasts 5.1 months average.
Hyperhidrosis
Axillary: 50IU per side (10-15 points). Palmar: 100IU per hand. Reduces sweating by 87% at 4 weeks.
Medical Professional Notice
Important: Individual response to neuromodulators varies significantly based on muscle mass, injection technique, and metabolic factors. Botulax 300IU must only be administered by licensed medical professionals trained in facial anatomy. Absolute contraindications include: neuromuscular disorders (myasthenia gravis, ALS), pregnancy/lactation, and concurrent aminoglycoside therapy.
This product is not FDA-approved. All treatment protocols should follow regional regulations. Monitor patients for 15 minutes post-injection for potential hypersensitivity reactions. Results typically last 4-6 months but may vary by ±30% between individuals.
